[New therapies against HCV].
Identifieur interne : 000E30 ( PubMed/Checkpoint ); précédent : 000E29; suivant : 000E31[New therapies against HCV].
Auteurs : Nathalie Kin [France] ; Astrid Vabret [France]Source :
- Revue francophone des laboratoires : RFL [ 1773-035X ] ; 2016.
Abstract
Human coronaviruses (HCoV) are single strand RNA viruses. To date, there are four so-called « classical » or « novel » HCoVs, characterized by a winter circulation. These coronaviruses are responsible for mild respiratory infection in general population. However, HCoVs are associated to more severe respiratory tract infection among susceptible population. Indeed, HCoVs account for 2 to 7% of hospitalizations due to a respiratory infection, particularly among children, immunocompromised or elderly people. Thereby, HCoVs are included in the panel of respiratory viruses detected in routine using molecular biology tools. These four circulating HCoVs have to be distinguished from the two emerging HCoVs: SARS-CoV and MERS-CoV. These later are associated to a more severe respiratory infection and differ from other HCoVs by their increased epidemic potential, their more important health impact, and their atypical circulation. Such as paramyxoviruses and Influenza viruses, coronaviruses have to be monitored due to their associated risk of emergence in human population from animal reservoirs.
DOI: 10.1016/S1773-035X(16)30369-0
PubMed: 32288826
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:32288826Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[New therapies against HCV].</title><author><name sortKey="Kin, Nathalie" sort="Kin, Nathalie" uniqKey="Kin N" first="Nathalie" last="Kin">Nathalie Kin</name><affiliation wicri:level="1"><nlm:affiliation>Unité de Recherche Risques Microbiens (EA4655), Université de Caen Normandie, Esplanade de la Paix, F-14000 Caen.</nlm:affiliation><country wicri:rule="zip">France</country><wicri:regionArea>F-14000 Caen</wicri:regionArea></affiliation></author><author><name sortKey="Vabret, Astrid" sort="Vabret, Astrid" uniqKey="Vabret A" first="Astrid" last="Vabret">Astrid Vabret</name><affiliation wicri:level="1"><nlm:affiliation>Laboratoire de virologie, CHU Caen, Avenue Georges Clemenceau, F-14000 Caen.</nlm:affiliation><country wicri:rule="zip">France</country><wicri:regionArea>F-14000 Caen</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:32288826</idno><idno type="pmid">32288826</idno><idno type="doi">10.1016/S1773-035X(16)30369-0</idno><idno type="wicri:Area/PubMed/Corpus">000E73</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000E73</idno><idno type="wicri:Area/PubMed/Curation">000E73</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000E73</idno><idno type="wicri:Area/PubMed/Checkpoint">000E30</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000E30</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[New therapies against HCV].</title><author><name sortKey="Kin, Nathalie" sort="Kin, Nathalie" uniqKey="Kin N" first="Nathalie" last="Kin">Nathalie Kin</name><affiliation wicri:level="1"><nlm:affiliation>Unité de Recherche Risques Microbiens (EA4655), Université de Caen Normandie, Esplanade de la Paix, F-14000 Caen.</nlm:affiliation><country wicri:rule="zip">France</country><wicri:regionArea>F-14000 Caen</wicri:regionArea></affiliation></author><author><name sortKey="Vabret, Astrid" sort="Vabret, Astrid" uniqKey="Vabret A" first="Astrid" last="Vabret">Astrid Vabret</name><affiliation wicri:level="1"><nlm:affiliation>Laboratoire de virologie, CHU Caen, Avenue Georges Clemenceau, F-14000 Caen.</nlm:affiliation><country wicri:rule="zip">France</country><wicri:regionArea>F-14000 Caen</wicri:regionArea></affiliation></author></analytic><series><title level="j">Revue francophone des laboratoires : RFL</title><idno type="ISSN">1773-035X</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Human coronaviruses (HCoV) are single strand RNA viruses. To date, there are four so-called « classical » or « novel » HCoVs, characterized by a winter circulation. These coronaviruses are responsible for mild respiratory infection in general population. However, HCoVs are associated to more severe respiratory tract infection among susceptible population. Indeed, HCoVs account for 2 to 7% of hospitalizations due to a respiratory infection, particularly among children, immunocompromised or elderly people. Thereby, HCoVs are included in the panel of respiratory viruses detected in routine using molecular biology tools. These four circulating HCoVs have to be distinguished from the two emerging HCoVs: SARS-CoV and MERS-CoV. These later are associated to a more severe respiratory infection and differ from other HCoVs by their increased epidemic potential, their more important health impact, and their atypical circulation. Such as paramyxoviruses and Influenza viruses, coronaviruses have to be monitored due to their associated risk of emergence in human population from animal reservoirs.</div></front></TEI><pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32288826</PMID><DateRevised><Year>2020</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1773-035X</ISSN><JournalIssue CitedMedium="Print"><Volume>2016</Volume><Issue>487</Issue><PubDate><Year>2016</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Revue francophone des laboratoires : RFL</Title><ISOAbbreviation>Rev Francoph Lab</ISOAbbreviation></Journal><ArticleTitle>[New therapies against HCV].</ArticleTitle><Pagination><MedlinePgn>25-33</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/S1773-035X(16)30369-0</ELocationID><Abstract><AbstractText>Human coronaviruses (HCoV) are single strand RNA viruses. To date, there are four so-called « classical » or « novel » HCoVs, characterized by a winter circulation. These coronaviruses are responsible for mild respiratory infection in general population. However, HCoVs are associated to more severe respiratory tract infection among susceptible population. Indeed, HCoVs account for 2 to 7% of hospitalizations due to a respiratory infection, particularly among children, immunocompromised or elderly people. Thereby, HCoVs are included in the panel of respiratory viruses detected in routine using molecular biology tools. These four circulating HCoVs have to be distinguished from the two emerging HCoVs: SARS-CoV and MERS-CoV. These later are associated to a more severe respiratory infection and differ from other HCoVs by their increased epidemic potential, their more important health impact, and their atypical circulation. Such as paramyxoviruses and Influenza viruses, coronaviruses have to be monitored due to their associated risk of emergence in human population from animal reservoirs.</AbstractText><CopyrightInformation>Copyright © 2016 Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kin</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Unité de Recherche Risques Microbiens (EA4655), Université de Caen Normandie, Esplanade de la Paix, F-14000 Caen.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vabret</LastName><ForeName>Astrid</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratoire de virologie, CHU Caen, Avenue Georges Clemenceau, F-14000 Caen.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Les infections à coronavirus humains.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2016</Year><Month>12</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Rev Francoph Lab</MedlineTA><NlmUniqueID>101264920</NlmUniqueID><ISSNLinking>1773-035X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Human coronavirus</Keyword><Keyword MajorTopicYN="N">diagnosis</Keyword><Keyword MajorTopicYN="N">respiratory infection</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>08</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2016</Year><Month>09</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32288826</ArticleId><ArticleId IdType="doi">10.1016/S1773-035X(16)30369-0</ArticleId><ArticleId IdType="pii">S1773-035X(16)30369-0</ArticleId><ArticleId IdType="pmc">PMC7140280</ArticleId></ArticleIdList><pmc-dir>pmcsd</pmc-dir>
<ReferenceList><Reference><Citation>N Engl J Med. 2012 Nov 8;367(19):1814-20</Citation><ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation><ArticleIdList><ArticleId IdType="pubmed">12690091</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Int J Infect Dis. 2014 Dec;29:307-8</Citation><ArticleIdList><ArticleId IdType="pubmed">25448335</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol Methods. 2001 Sep;97(1-2):59-66</Citation><ArticleIdList><ArticleId IdType="pubmed">11483217</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>East Mediterr Health J. 2013;19 Suppl 1:S12-8</Citation><ArticleIdList><ArticleId IdType="pubmed">23888790</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Neurology. 1982 Mar;32(3):292-5</Citation><ArticleIdList><ArticleId IdType="pubmed">6278362</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Chem. 2003 Jun;49(6 Pt 1):953-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12765993</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Mol Cell Probes. 1994 Oct;8(5):357-64</Citation><ArticleIdList><ArticleId IdType="pubmed">7877631</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Pediatr Infect Dis J. 2013 Apr;32(4):325-9</Citation><ArticleIdList><ArticleId IdType="pubmed">23337903</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Environ Health. 2006 May;68(9):26-30; quiz 51-2</Citation><ArticleIdList><ArticleId IdType="pubmed">16696450</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nat Med. 2004 Dec;10(12 Suppl):S88-97</Citation><ArticleIdList><ArticleId IdType="pubmed">15577937</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet Infect Dis. 2014 Feb;14(2):93-4</Citation><ArticleIdList><ArticleId IdType="pubmed">24355867</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet Infect Dis. 2013 Sep;13(9):745-51</Citation><ArticleIdList><ArticleId IdType="pubmed">23782859</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Virol. 2014 Jun;60(2):168-71</Citation><ArticleIdList><ArticleId IdType="pubmed">24726679</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>EMBO J. 1987 Dec 1;6(12):3779-85</Citation><ArticleIdList><ArticleId IdType="pubmed">3428275</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Influenza Other Respir Viruses. 2013 Nov;7(6):1040-7</Citation><ArticleIdList><ArticleId IdType="pubmed">23462106</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2014 Aug;20(8):1319-22</Citation><ArticleIdList><ArticleId IdType="pubmed">25075637</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Microbiol. 2004 May;42(5):2043-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15131168</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):311-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15030703</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2012 Apr;86(7):3995-4008</Citation><ArticleIdList><ArticleId IdType="pubmed">22278237</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2014 Apr;20(4):552-9</Citation><ArticleIdList><ArticleId IdType="pubmed">24655412</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6212-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15073334</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2012 Dec;86(23):12816-25</Citation><ArticleIdList><ArticleId IdType="pubmed">22993147</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1986-94</Citation><ArticleIdList><ArticleId IdType="pubmed">12682352</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12781535</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Euro Surveill. 2015 Jun 25;20(25):7-13</Citation><ArticleIdList><ArticleId IdType="pubmed">26132767</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2001 Jan;75(1):506-12</Citation><ArticleIdList><ArticleId IdType="pubmed">11119619</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Microbiol. 2010 Aug;48(8):2940-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20554810</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1967 Apr;57(4):933-40</Citation><ArticleIdList><ArticleId IdType="pubmed">5231356</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Am J Pathol. 2016 Mar;186(3):652-8</Citation><ArticleIdList><ArticleId IdType="pubmed">26857507</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Virol. 2007 Mar;38(3):244-50</Citation><ArticleIdList><ArticleId IdType="pubmed">17222582</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol Methods. 1998 Jun;72(2):145-52</Citation><ArticleIdList><ArticleId IdType="pubmed">9694322</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2013 Jun 29;381(9885):2265-72</Citation><ArticleIdList><ArticleId IdType="pubmed">23727167</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Curr Top Microbiol Immunol. 1982;99:131-63</Citation><ArticleIdList><ArticleId IdType="pubmed">7047085</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Clin Vaccine Immunol. 2008 Dec;15(12):1805-10</Citation><ArticleIdList><ArticleId IdType="pubmed">18945884</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2006 Jul;80(14):7270-4</Citation><ArticleIdList><ArticleId IdType="pubmed">16809333</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Feb;10(2):294-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15030700</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Neurol Sci. 1976 May;28(1):121-6</Citation><ArticleIdList><ArticleId IdType="pubmed">932771</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Microbiol. 2005 Nov;43(11):5452-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16272469</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>mBio. 2012 Nov 20;3(6):</Citation><ArticleIdList><ArticleId IdType="pubmed">23170002</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 1967 Aug;1(4):810-6</Citation><ArticleIdList><ArticleId IdType="pubmed">4912236</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Gastroenterology. 2003 Oct;125(4):1011-7</Citation><ArticleIdList><ArticleId IdType="pubmed">14517783</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Med Virol. 2005 Mar;75(3):463-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15648061</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 Oct 25;362(9393):1353-8</Citation><ArticleIdList><ArticleId IdType="pubmed">14585636</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Euro Surveill. 2012 Oct 04;17(40):20290</Citation><ArticleIdList><ArticleId IdType="pubmed">23078800</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Microbiol. 2008 Jul;46(7):2368-73</Citation><ArticleIdList><ArticleId IdType="pubmed">18495857</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nat Med. 2004 Apr;10(4):368-73</Citation><ArticleIdList><ArticleId IdType="pubmed">15034574</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Infect Dis. 2005 Dec 1;192(11):1898-907</Citation><ArticleIdList><ArticleId IdType="pubmed">16267760</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Virol. 2005 Jan;79(2):884-95</Citation><ArticleIdList><ArticleId IdType="pubmed">15613317</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2005 Dec;11(12):1860-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16485471</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2014 Dec;20(12):2093-5</Citation><ArticleIdList><ArticleId IdType="pubmed">25425139</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Euro Surveill. 2013 Sep 05;18(36):pii=20574</Citation><ArticleIdList><ArticleId IdType="pubmed">24079378</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Infect Dis. 2013 Nov 15;208(10):1634-42</Citation><ArticleIdList><ArticleId IdType="pubmed">23922367</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li></country></list><tree><country name="France"><noRegion><name sortKey="Kin, Nathalie" sort="Kin, Nathalie" uniqKey="Kin N" first="Nathalie" last="Kin">Nathalie Kin</name></noRegion><name sortKey="Vabret, Astrid" sort="Vabret, Astrid" uniqKey="Vabret A" first="Astrid" last="Vabret">Astrid Vabret</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E30 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000E30 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:32288826
|texte= [New therapies against HCV].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:32288826" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |